CHICAGO (GenomeWeb) – Bioinformatics software developer GenomOncology this month announced a deal to license technology from the University of Nebraska Medical Center that automates the coding and mining of molecular pathology test results to help clinicians assess the efficacy of targeted cancer treatments.
Get the full story with
GenomeWeb Premium Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.